Overall, this is similar to that of AQP4-IgG+NMOSD (0.4–7.3/million) (41, 43), and markedly lower than that of MS (7–144/million) (42, 44), accepting a wide geographical variability. This evidence concerns the gene AQP4 and myeloid sarcoma.